Welcome to LookChem.com Sign In|Join Free
  • or
Pyridine, 3-(1-phenylhydrazino)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

95519-88-3

Post Buying Request

95519-88-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

95519-88-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 95519-88-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,5,1 and 9 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 95519-88:
(7*9)+(6*5)+(5*5)+(4*1)+(3*9)+(2*8)+(1*8)=173
173 % 10 = 3
So 95519-88-3 is a valid CAS Registry Number.

95519-88-3Downstream Products

95519-88-3Relevant academic research and scientific papers

Palladium-catalyzed monoarylation of arylhydrazines with aryl tosylates

Huang, Yange,Choy, Pui Ying,Wang, Junya,Tse, Man-Kin,Raymond Wai-Yin Sun,Albert Sun-Chi Chan,Kwong, Fuk Yee

, p. 14664 - 14673 (2020/12/29)

A palladium-catalyzed C-N bond coupling reaction between arylhydrazines and aryl tosylates for facile synthesis of unsymmetrical N,N-diarylhydrazines has been developed. Employing the catalyst system of Pd(TFA)2 associated with newly developed phosphine ligand L1, the monoarylation of arylhydrazine proceeds smoothly to afford desired products in good-to-excellent yields (up to 95%) with good functional group compatibility. This method provides an alternative synthetic pathway for accessing structurally diversified N,N-diarylhydrazines from simple and easily accessible coupling components.

Quinoline derivatives as neurokinin receptor antagonists

-

Page/Page column 34, (2009/04/24)

The present invention relates to substituted quinoline hydrazides of Formula (I): wherein R1, R2, R3, R4, R5, X, Y and Z are defined herein, pharmaceutical compositions comprising them and their use in treating diseases mediated by neurokinin-2 and/or neurokinin-3 (NK-3) receptors. These compounds can thus be used in methods of treatment to suppress and treat such disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 95519-88-3